Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices 87589 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

The National Violence Death 

Reporting System (NVDRS) (OMB 

Control No. 0920–0607, Exp. 9/30/ 

2025)—Revision—National Center for 

Injury Prevention and Control (NCIPC), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Violence against others or oneself is a 

major public health problem in the 

United States and is a particular 

problem for the young: suicide and 

homicide were among the top four 

leading causes of death for Americans 

10–44 and 1–34 years of age in 2022. A 

key to preventing these violent deaths is 

to understand and target their 

circumstances. Given the magnitude of 

the problem, it is noteworthy that no 

national surveillance system for violent 

deaths existed in the U.S. until the 

National Violent Death Reporting 

System (NVDRS) was developed. 

NVDRS is a state-based surveillance 

system developed to monitor the 

occurrence of violent deaths (e.g., 

homicide, suicide, deaths due to legal 

intervention, deaths of undetermined 

intent, and unintentional firearm 

deaths) in the U.S. by collecting 

comprehensive data from multiple 

sources (e.g., death certificates, coroner/ 

medical examiner reports, law 

enforcement reports) into a useable, 

anonymous database. 

CDC received initial OMB approval 

for NVDRS in November 2004 and 

renewals through July 2020. This 

Revision request includes several minor 

updates: (1) implement updates to the 

web-based system to improve 

performance, functionality, and 

accessibility; (2) add new data elements 

to the system; and (3) make minimal 

revisions to the NVDRS Coding Manual. 

The School Associated Violent Death 

(SAVD) module was added in the 

previous Revision request on July 2020, 

due to the discontinuation of the SAVD 

Surveillance System (OMB Control No. 

0920–0604). SAVD currently monitors 

school-associated violent deaths across 

the U.S. by abstracting data from media 

reports. These data play an important 

role in assessing national trends in 

school-associated violent deaths and 

helping inform efforts to prevent fatal 

school violence. To address duplication, 

the SAVD was phased out and the 

SAVD module in NVDRS will capture in 

depth information about such incidents. 

The Public Safety Officer Suicide 

Reporting module was also added to the 

system to capture more detailed 

information on suicides among public 

safety officers. This module includes 

information specific to first responders 

and builds upon elements collected as 

part of current NVDRS. Like the SAVD 

module, it is a tab in the NVDRS webbased system that only applies to a 

subset of incidents. 

NVDRS is an ongoing surveillance 

system that captures annual violent 

death counts, CDC aggregates deidentified data from each state into one 

national database that is analyzed and 

released in annual reports and other 

publications. A restricted access 

database is available for researchers to 

request access to NVDRS data for 

analysis and a web-based query system 

is open for public use that allows for 

electronic querying of data. NVDRS 

generates public health surveillance 

information at the national, state, and 

local levels that is more detailed, useful, 

and timely. The information helps 

identify where prevention efforts need 

to be focused. CDC requests OMB 

approval for an estimated 41,827 annual 

burden hours. There are no costs to 

respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Public Agencies ............. Web-based Data Entry ........................................ 56 1,350 30/60 37,800 

School Associated Violent Death Module ........... 45 1 30/60 23 

Public Safety Officer Suicide Reporting Module 56 429 10/60 4,004 

Total ........................ .............................................................................. ........................ ........................ ........................ 41,827 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–25555 Filed 11–1–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–D–0055] 

Voluntary Sodium Reduction Goals: 

Target Mean and Upper Bound 

Concentrations for Sodium in 

Commercially Processed, Packaged, 

and Prepared Foods (Edition 2); Draft 

Guidance for Industry; Extension of 

Comment Period 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of availability; extension 

of comment period. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

extending the comment period for a 

draft guidance for industry entitled 

‘‘Voluntary Sodium Reduction Goals: 

Target Mean and Upper Bound 

Concentrations for Sodium in 

Commercially Processed, Packaged, and 

Prepared Foods (Edition 2).’’ The draft 

guidance, when finalized, will describe 

our views on the next voluntary goals 

(Phase II (3-year)) for sodium reduction 

in a variety of identified categories of 


lotter on DSK11XQN23PROD with NOTICES1
87590 Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices 

foods that are commercially processed, 

packaged, or prepared. These goals are 

intended to address the excessive intake 

of sodium in the current population to 

help reduce the burden of diet-related 

chronic disease, promote improvements 

in public health, and advance health 

equity by supporting a healthier food 

supply. The Agency is taking this action 

in response to requests for an extension 

to allow interested persons additional 

time to submit comments. 

DATES: Submit either electronic or 

written comments on the draft guidance 

by January 13, 2025, to ensure that we 

consider your comment on the draft 

guidance before we begin work on the 

final version of the guidance. 

ADDRESSES: You may submit comments 

on any guidance at any time as follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2014–D–0055 for ‘‘Voluntary Sodium 

Reduction Goals: Target Mean and 

Upper Bound Concentrations for 

Sodium in Commercially Processed, 

Packaged, and Prepared Foods (Edition 

2).’’ Received comments will be placed 

in the docket and, except for those 

submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ We 

will review this copy, including the 

claimed confidential information, in our 

consideration of comments. The second 

copy, which will have the claimed 

confidential information redacted/ 

blacked out, will be available for public 

viewing and posted on https://

www.regulations.gov. Submit both 

copies to the Dockets Management Staff. 

If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://

www.govinfo.gov/content/pkg/FR-2015- 

09-18/pdf/2015-23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852, 240–402–7500. 

You may submit comments on any 

guidance at any time (see 21 CFR 

10.115(g)(5)). 

Submit written requests for single 

copies of the draft guidance to the 

Nutrition Center of Excellence, Human 

Foods Program, Food and Drug 

Administration, 5001 Campus Dr., 

College Park, MD 20740. Send two selfaddressed adhesive labels to assist that 

office in processing your request. See 

the SUPPLEMENTARY INFORMATION section 

for electronic access to the draft 

guidance. 

FOR FURTHER INFORMATION CONTACT: 

Kasey Heintz, Nutrition Center of 

Excellence, Human Foods Program, 

Food and Drug Administration, 5001 

Campus Dr., College Park, MD 20740, 

240–402–1376. 

SUPPLEMENTARY INFORMATION: 

In the Federal Register of August 16, 

2024 (89 FR 66727), we published a 

notice announcing the availability of a 

draft guidance entitled, ‘‘Voluntary 

Sodium Reduction Goals: Target Mean 

and Upper Bound Concentrations for 

Sodium in Commercially Processed, 

Packaged, and Prepared Foods; Draft 

Guidance for Industry (Edition 2).’’ The 

draft guidance, when finalized, will 

describe our views on the next 

voluntary goals (Phase II (3-year)) for 

sodium reduction in a variety of 

identified categories of foods that are 

commercially processed, packaged, or 

prepared. We provided a 90-day 

comment period for the draft guidance. 

We have received requests for a 90- 

day extension of the comment period. In 

general, the requests explained that 

industry needed more time to 

thoroughly review the draft guidance 

against numerous product lines and that 

industry also anticipates a need to 

manage multiple critical initiatives from 

FDA, including a final rule on ‘‘healthy’’ 

labeling and a proposed rule on frontof-package nutrition labeling. 

We have considered the requests and 

are extending the comment period for 

an additional 60 days until January 13, 

2025. We believe that this extension 

will allow adequate time for interested 

persons to submit comments without 

significantly delaying finalizing the 

guidance. 

Dated: October 29, 2024. 

Kimberlee Trzeciak, 

Deputy Commissioner for Policy, Legislation, 

and International Affairs. 

[FR Doc. 2024–25567 Filed 11–1–24; 8:45 am] 

BILLING CODE 4164–01–P 


lotter on DSK11XQN23PROD with NOTICES1